Amplia Therapeutics Ltd.ASX: ATX

Preliminary Toxicology Studies Support Phase1 Clinical Trial

Jun 30, 2020 at 4:34 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment